Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager

Zealand Pharma A/S

CSE:ZEAL

Watchlist

Dividends

Price: 726.5 DKK 4.23% Market Closed

Market Cap: 51.5B DKK

Have any thoughts about
Zealand Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 726.5 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ZEAL Alert

Zealand Pharma A/S

726.5

+29.5 (+4.23%)

52 Week Range	315.4 954
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Zealand Pharma A/S

What unique competitive advantages
does Zealand Pharma A/S hold over its rivals?

What risks and challenges
does Zealand Pharma A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Zealand Pharma A/S.

What unique competitive advantages
does Zealand Pharma A/S hold over its rivals?

What risks and challenges
does Zealand Pharma A/S face in the near future?

Summarize the latest earnings call
of Zealand Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zealand Pharma A/S.

Provide P/S
for Zealand Pharma A/S.

Provide P/E
for Zealand Pharma A/S.

Provide P/OCF
for Zealand Pharma A/S.

Provide P/FCFE
for Zealand Pharma A/S.

Provide P/B
for Zealand Pharma A/S.

Provide EV/S
for Zealand Pharma A/S.

Provide EV/GP
for Zealand Pharma A/S.

Provide EV/EBITDA
for Zealand Pharma A/S.

Provide EV/EBIT
for Zealand Pharma A/S.

Provide EV/OCF
for Zealand Pharma A/S.

Provide EV/FCFF
for Zealand Pharma A/S.

Provide EV/IC
for Zealand Pharma A/S.

Show me price targets
for Zealand Pharma A/S made by professional analysts.

What are the Revenue projections
for Zealand Pharma A/S?

How accurate were the past Revenue estimates
for Zealand Pharma A/S?

What are the Net Income projections
for Zealand Pharma A/S?

How accurate were the past Net Income estimates
for Zealand Pharma A/S?

What are the EPS projections
for Zealand Pharma A/S?

How accurate were the past EPS estimates
for Zealand Pharma A/S?

What are the EBIT projections
for Zealand Pharma A/S?

How accurate were the past EBIT estimates
for Zealand Pharma A/S?

Compare the revenue forecasts
for Zealand Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zealand Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zealand Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zealand Pharma A/S compared to its peers.

Compare the P/E ratios
of Zealand Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Zealand Pharma A/S with its peers.

Analyze the financial leverage
of Zealand Pharma A/S compared to its main competitors.

Show all profitability ratios
for Zealand Pharma A/S.

Provide ROE
for Zealand Pharma A/S.

Provide ROA
for Zealand Pharma A/S.

Provide ROIC
for Zealand Pharma A/S.

Provide ROCE
for Zealand Pharma A/S.

Provide Gross Margin
for Zealand Pharma A/S.

Provide Operating Margin
for Zealand Pharma A/S.

Provide Net Margin
for Zealand Pharma A/S.

Provide FCF Margin
for Zealand Pharma A/S.

Show all solvency ratios
for Zealand Pharma A/S.

Provide D/E Ratio
for Zealand Pharma A/S.

Provide D/A Ratio
for Zealand Pharma A/S.

Provide Interest Coverage Ratio
for Zealand Pharma A/S.

Provide Altman Z-Score Ratio
for Zealand Pharma A/S.

Provide Quick Ratio
for Zealand Pharma A/S.

Provide Current Ratio
for Zealand Pharma A/S.

Provide Cash Ratio
for Zealand Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Zealand Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Zealand Pharma A/S?

What is the current Free Cash Flow
of Zealand Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zealand Pharma A/S.

P/S
Price to Sales

667.7

Current

86.6

Median

7.7

Industry

Higher than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

667.7

Market Cap

51.3B DKK

Revenue

76.9m DKK

All Countries

Forward Multiples

			Market Cap	P/S
DK		Zealand Pharma A/S CSE:ZEAL	51.3B DKK	667.7
FR		Pharnext SCA OTC:PNEXF	6T USD	38 083 264.3
US		Abbvie Inc NYSE:ABBV	312.7B USD	5.6
US		Amgen Inc NASDAQ:AMGN	158.3B USD	4.9
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	10.9
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	4
US	E	Epizyme Inc F:EPE	94.1B EUR	1 849.9
AU		CSL Ltd ASX:CSL	133.6B AUD	5.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	5.9
US	S	Seagen Inc F:SGT	39.3B EUR	17.8
NL		argenx SE XBRU:ARGX	34.8B EUR	18.7

				Revenue Growth
DK		Zealand Pharma A/S CSE:ZEAL	Average P/S: 3 462 350.5 667.7	497%
FR		Pharnext SCA OTC:PNEXF	38 083 264.3	N/A
US		Abbvie Inc NYSE:ABBV	5.6	20%
US		Amgen Inc NASDAQ:AMGN	4.9	26%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	10.9	33%
US		Gilead Sciences Inc NASDAQ:GILD	4	10%
US	E	Epizyme Inc F:EPE	1 849.9	N/A
AU		CSL Ltd ASX:CSL	5.9	23%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	5.9	23%
US	S	Seagen Inc F:SGT	17.8	118%
NL		argenx SE XBRU:ARGX	18.7	220%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

307.6

2-Years Forward

P/S

69.4

3-Years Forward

P/S

25.1

Zealand Pharma A/S
CSE:ZEAL

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Zealand Pharma A/S CSE:ZEAL

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Zealand Pharma A/S
CSE:ZEAL

P/S
Price to Sales